1. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient

2. Panelists

3. Program Goals

4. Case Study

5. Current Medications

6. Case Study (cont)

7. Lipid Guidelines for Patients With ASCVD Secondary Prevention

8. Treatment of Hypertension in Those With Known Coronary Artery Disease

9. Antiplatelet Therapy in Secondary Prevention

11. Mechanism of Action of Aspirin

12. What Is the Right Dose of Aspirin?

14. Aspirin Tolerability and Safety

15. Aspirin Adherence and Treatment Discontinuation

16. Aspirin Resistance

17. Diabetes: A Prothrombotic State

18. Primary Outcomes at 4 Years Among REACH Registry Patients

19. Back to Our Patient…

20. Other Factors That May Be Associated With Aspirin Resistance

21. Types of Aspirin Formulations Currently Available

24. Aims of DURATION Study

25. DURATION Study Methods

26. DURATION Study Results

27. DURATION Study Conclusion

29. Conclusion

30. Abbreviations

31. Abbreviations (cont)

32. Abbreviations (cont)